Literature DB >> 24345750

Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding.

Youn K Shim1, Jane M Rachel, Paolo Ghia, Jeff Boren, Fatima Abbasi, Antonis Dagklis, Geri Venable, Jiyeon Kang, Heba Degheidy, Fred V Plapp, Robert F Vogt, Jay E Menitove, Gerald E Marti.   

Abstract

Circulating monoclonal B cells may be detected in healthy adults, a condition called monoclonal B-cell lymphocytosis (MBL). MBL has also been identified in donated blood, but no systematic study of blood donors has been reported. Using sensitive and specific laboratory methods, we detected MBL in 149 (7.1%; 95% confidence interval, 6.0% to 8.3%) of 2098 unique donors ages 45 years or older in a Midwestern US regional blood center between 2010 and 2011. Most of the 149 donors had low-count MBL, including 99 chronic lymphocytic leukemia-like (66.4%), 22 atypical (14.8%), and 19 CD5(-) (12.8%) immunophenotypes. However, 5 donors (3.4%) had B-cell clonal counts above 500 cells per µL, including 3 with 1693 to 2887 cells per µL; the clone accounted for nearly all their circulating B cells. Four donors (2.7%) had 2 distinct MBL clones. Of 51 MBL samples in which immunoglobulin heavy chain (IGH)V-D-J genotypes could be determined, 71% and 29% used IGHV3- and IGHV4-family genes, respectively. Sequencing revealed 82% with somatic hypermutation, whereas 18% had >98% germ-line identity, including 5 with entirely germ-line sequences. In conclusion, MBL prevalence is much higher in blood donors than previously reported, and although uncommon, the presence of high-count MBL warrants further investigations to define the biological fate of the transfused cells in recipients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24345750      PMCID: PMC3938146          DOI: 10.1182/blood-2013-08-523704

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly.

Authors:  Paolo Ghia; Giuseppina Prato; Cristina Scielzo; Stefania Stella; Massimo Geuna; Giuseppe Guida; Federico Caligaris-Cappio
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

2.  IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis.

Authors:  Véronique Giudicelli; Denys Chaume; Marie-Paule Lefranc
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

3.  Easy SAS calculations for risk or prevalence ratios and differences.

Authors:  Donna Spiegelman; Ellen Hertzmark
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

4.  Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy.

Authors:  A C Rawstron; B Kennedy; P A Evans; F E Davies; S J Richards; A P Haynes; N H Russell; G Hale; G J Morgan; A S Jack; P Hillmen
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

Review 5.  Diagnostic criteria for monoclonal B-cell lymphocytosis.

Authors:  Gerald E Marti; Andy C Rawstron; Paolo Ghia; Peter Hillmen; Richard S Houlston; Neil Kay; Thérèse A Schleinitz; Neil Caporaso
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

6.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia.

Authors:  Gerald E Marti; Patricia Carter; Fatima Abbasi; Glennelle C Washington; Nisha Jain; Vincent E Zenger; Naoko Ishibe; Lynn Goldin; Laura Fontaine; Nancy Weissman; Maria Sgambati; Guy Fauget; Pablo Bertin; Robert F Vogt; Barbara Slade; Philip D Noguchi; M A Stetler-Stevenson; Neil Caporaso
Journal:  Cytometry B Clin Cytom       Date:  2003-03       Impact factor: 3.058

9.  Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.

Authors:  Andy C Rawstron; Martin R Yuille; Julie Fuller; Matthew Cullen; Ben Kennedy; Stephen J Richards; Andrew S Jack; Estella Matutes; Daniel Catovsky; Peter Hillmen; Richard S Houlston
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

10.  Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Xinjun Li; Kari Hemminki
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

View more
  25 in total

1.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Authors:  David P Steensma; Rafael Bejar; Siddhartha Jaiswal; R Coleman Lindsley; Mikkael A Sekeres; Robert P Hasserjian; Benjamin L Ebert
Journal:  Blood       Date:  2015-04-30       Impact factor: 22.113

Review 2.  Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia.

Authors:  Yoshikane Kikushige; Toshihiro Miyamoto
Journal:  Int J Hematol       Date:  2015-02-03       Impact factor: 2.490

Review 3.  Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.

Authors:  Paolo Strati; Tait D Shanafelt
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

Review 4.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

5.  Monoclonal B-cell lymphocytosis in donors.

Authors:  Maryalice Stetler-Stevenson
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

Review 6.  Minimal residual disease in multiple myeloma: bringing the bench to the bedside.

Authors:  Sham Mailankody; Neha Korde; Alexander M Lesokhin; Nikoletta Lendvai; Hani Hassoun; Maryalice Stetler-Stevenson; Ola Landgren
Journal:  Nat Rev Clin Oncol       Date:  2015-01-27       Impact factor: 66.675

7.  Clinical relevance of silent red blood cell autoantibodies.

Authors:  Francesca R Mauro; Fabio Trastulli; Cristiano Alessandri; Guido Valesini; Gianluca Giovannetti; Costantino Riemma; Marika Porrazzo; Sara Pepe; Gioia Colafigli; Maria D Caputo; Maria S De Propris; Anna R Guarini; Gabriella Girelli; Serelina Coluzzi; Robin Foà
Journal:  Haematologica       Date:  2017-09-21       Impact factor: 9.941

8.  High frequency of chronic lymphocytic leukemia-like low-count monoclonal B-cell lymphocytosis in Japanese descendants living in Brazil.

Authors:  Mariane de Faria-Moss; Mihoko Yamamoto; Celso Arrais-Rodrigues; Ignacio Criado; Caio Perez Gomes; Maria de Lourdes Chauffaille; Matheus Vescovi Gonçalves; Eliza Kimura; Efstathios Koulieris; Fabio Borges; Guilhermo Dighiero; Joao Bosco Pesquero; Julia Almeida; Alberto Orfao
Journal:  Haematologica       Date:  2019-11-14       Impact factor: 9.941

Review 9.  Sixty as the new forty: considerations on older related stem cell donors.

Authors:  P Anderlini
Journal:  Bone Marrow Transplant       Date:  2016-08-08       Impact factor: 5.483

Review 10.  Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis.

Authors:  Yoshikane Kikushige; Toshihiro Miyamoto
Journal:  Int J Hematol       Date:  2014-08-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.